Bagsværd, Denmark, 2 January 2014 - In continuation of the company's announcements dated 31 January 2013 and 31 October 2013 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE: NVO) and its wholly-owned affiliates on 31 December 2013 owned 102,852,025 of its own B shares of DKK 0.20, corresponding to a total nominal value of DKK 20,570,405 or 3.7% of the total share capital.
In the fourth quarter of 2013 a total of 15,327,405 B shares of DKK 0.20 were repurchased, and 1,940,620 B shares of DKK 0.20 were disposed of to employees in connection with employee incentive programmes.
